MEDS Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Marijuana Effective Drug Studies Act of 2018 or the MEDS Act
This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana.
Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 4825: MEDS Act. 115th Congress. Open America. https://openamerica.io/bill/115-HR-4825/
"H.R. 4825: MEDS Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-4825/.
H.R. 4825, 115th Cong. (2026), https://openamerica.io/bill/115-HR-4825/.
[H.R. 4825: MEDS Act](https://openamerica.io/bill/115-HR-4825/)